Claim Missing Document
Check
Articles

Found 28 Documents
Search

Energy Medicine: Cutting-Edge Modalities Rehan Haider; Asghar Mehdi; Anjum Zehra
International Journal of Integrative Sciences Vol. 3 No. 2 (2024): February 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijis.v3i2.7279

Abstract

Energy medicine is a dynamic and evolving area that investigates novel therapeutic techniques that use the body's energy systems to promote healing and well-being. This abstract digs into cutting-edge energy medicine techniques, emphasizing their novel approaches and possible implications for healthcare. Recent advances in energy medicine have resulted in unique methods that extend beyond standard therapy. Techniques like bio-field therapies, vibrational medicine, and frequency-based interventions are gaining popularity for their capacity to impact the body's subtle energy fields. These methods are based on the idea that disruptions in the body's energy flow lead to physical and mental health problems, and that restoring balance can help recover. Biofield therapies, such as Reiki and therapeutic touch, involve practitioners sending energy into the recipient's energy field to encourage relaxation and trigger self-healing mechanisms. Vibrational medicine investigates the application of specific frequencies, noises, or vibrations to correct energy imbalances. Cutting-edge technologies that use electromagnetic frequencies have been designed to address specific health conditions, revealing its potential in areas such as pain management and tissue regeneration. Furthermore, energy medicine interacts with technology via biofeedback and bioresonance devices, allowing people to monitor and control their energy reactions. These methods provide a more individualized approach to healthcare, tailoring interventions to each individual's unique energy patterns
Human Monkeypox Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das
International Journal of Integrative Sciences Vol. 3 No. 3 (2024): March 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijis.v3i3.7337

Abstract

Human monkeypox is a unique fervid disease caused by a monkeypox bacterium, an appendage of the Orthopoxvirus genus. Affliction exhibits epidemiological and dispassionate traits that pose challenges for disease and prevention. Primarily native to the Central and West African domains, monkeypox has gained worldwide attention because of occasional outbreaks and the potential for human-to-human broadcast. Epidemiologically, monkeypox shares similarities with smallpox, including reservoirs likely to contain rodents and non-human anthropoids. The virus may be transmitted to people through direct contact with infected mammals or bodily fluids. Person-to-person broadcasts, even though meager, contribute to the spread of ailments, stressing the need for active stopping strategies. Clinical evidence of human monkeypox includes delirium, problems, muscle aches, and a characteristic rash. The range of ailment asperity ranges from mild, self-confining cases to harsh forms accompanying obstacles, underscoring the importance of correct and appropriate diseases. However, distinguishing monkeypox from other rash ailments, including smallpox and chickenpox, is a challenge. The prevention of human monkeypox relies on early discovery and immunization. Surveillance works aim to monitor and contain outbreaks, whereas expeditious demonstrative tests influence up-to-the-minute case identification. Vaccination, accompanying the existing smallpox cure, has proven promising in preventing monkeypox and lowering the severity of the affliction. However, continuous research is crucial to evolving guide attacks, particularly given the disadvantages of the smallpox cure and the progressing type of virus
Corruption in the Pharmaceutical Sector Diagnosing the Challenges Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed
International Journal of Integrative Sciences Vol. 3 No. 3 (2024): March 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijis.v3i3.7728

Abstract

Corruption inside the pharmaceutical industry is a pervasive and complicated problem that poses giant challenges to healthcare structures, public welfare, and ethical requirements. This abstract delves into the prognosis of the challenges posed by corruption in the pharmaceutical industry. The pharmaceutical sector performs a vital function in promoting international fitness by growing, generating, and distributing life-saving medicines. However, the arena is plagued by various kinds of corruption, such as bribery, fraud, kickbacks, and undue influence on regulatory procedures. This corruption leads to distorted priorities, compromised drug satisfaction, decreased access to important drug treatments, and expanded healthcare costs. One challenge is the complex web of relationships among pharmaceutical corporations, healthcare professionals, and regulatory governments. These relationships, while regularly critical for understanding trade and innovation, may be exploited for corrupt practices that prioritize income over patient well-being. Furthermore, inadequate regulation and susceptible enforcement mechanisms create an environment where corrupt activities can flourish
In Vitro Antioxidative Activity of some Medicinal Plants Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed; Sambreen Zameer
International Journal of Integrative Sciences Vol. 3 No. 4 (2024): April 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijis.v3i4.7999

Abstract

The artificial antioxidative exercise of curative plants is a topic of meaningful interest on account of the potential healing benefits they concede they offer in fighting oxidative stress-related ailments. This study proposes to judge the antioxidant properties of picked medicinal plants using artificial assays. A range of plants famous for their established curative uses was chosen for inspection, containing [put plant names]. The methods complicated extracting bioactive compounds from the plant fabrics utilizing appropriate solvents and determining their antioxidative potential through miscellaneous assays such as DPPH radical scavenging endeavor, tough lowering antioxidant capacity (FRAP), and total phenolic content decision. These assays provide insights into the strength of the plant extracts to counteract free radicals and defeat oxidative damage. Results marked variable degrees of the antioxidative project between the proven plants, with a few exhibiting effective scavenging facilities against free radicals, while the remainder of something displayed notable phenolic content. These judgments underscore the variety of antioxidative means present in curative plants and desire their potential serviceability as natural beginnings of antioxidants for healing purposes
Nutraceuticals in Diabetes Management Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed
International Journal of Integrative Sciences Vol. 3 No. 4 (2024): April 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijis.v3i4.8158

Abstract

Nutraceuticals, a suitcase of "food" and "pharmaceuticals," represent a blooming field in the administration of diabetes. With the all-encompassing predominance of diabetes reaching its disquieting dimensions, there is a growing need for complete approaches to complement normal analyses. Nutraceuticals, including bioactive compounds derived from snack beginnings, have attracted attention for their potential to prevent and treat diabetes.Polyphenols in various products, legumes, and teas have shown antagonistic diabetic properties by modulating sweet substance absorption and insulin sensitivity. curcumin fatty Curcumin, a bioactive compound in turmeric, demonstrates antagonistic-instigative and antioxidant properties, providing improved glycemic control. Omega-3 fatty acids, which are widespread in extricate oils, exhibit insulin-sensitizing properties and can diminish diabetic complexities. Additionally, dietary texture—a plethora of whole grains and legumes—aids the level of glucose in blood management and pressure administration. Nutraceuticals offer further glycemic control; however, they still address the associated problems of diabetes. Antioxidant-rich vitamins, such as C and E, protect against oxidative stress, which is involved in diabetic complications. insulin. Furthermore, certain minerals, to a certain degree chromium and magnesium, play crucial roles in insulin, indicating oxygen absorption
Modern Medicine and Pharmaceutics Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed; Sambreen Zameer
International Journal of Integrative Sciences Vol. 3 No. 4 (2024): April 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijis.v3i4.8225

Abstract

Modern Medicine and pharmaceuticals have made tremendous strides in enhancing the healthcare and quality of life of people worldwide. This summary explores the key traits and trends in these fields. In recent decades, current medications have witnessed a paradigm shift toward personalized healthcare. Improvements in genomics, proteomics, and record analytics have paved the way for precision medication and tailoring treatments for an individual's genetic makeup. This technique enhances treatment efficacy while minimizing aspect consequences, marking a significant departure from the one-size-fits-all approach. Pharmaceutical research has experienced a revolution with the advent of biotechnology. Biopharmaceuticals, along with monoclonal antibodies and gene treatment plans, have emerged as powerful tools for the fight against formerly untreatable illnesses. Their ability to target specific molecules or genes has opened new frontiers in cancer treatment, uncommon illnesses, and autoimmune diseases. Furthermore, pharmaceutical enterprises have embraced virtual technologies. AI-pushed drug discovery, in silico medical trials, and telemedicine reshape the drug development pipeline and improve the care of affected persons. In particular, telemedicine has gained prominence, presenting available healthcare offerings and far-flung tracking. However, these advancements have moral and regulatory demands. Privateness issues, information protection, and equitable access to present-day remedies remain essential issues. The need for strong moral frameworks and regulatory oversight is paramount
Obesity Policy: Opportunities for Functional Food Market Growth Rehan Haider; Asghar Mehdi
International Journal of Applied Economics, Accounting and Management (IJAEAM) Vol. 1 No. 4 (2023): November 2023
Publisher : MultiTech Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59890/ijaeam.v1i4.912

Abstract

The all-encompassing rise in corpulence rates has prompted a reevaluation of community health tactics and has unlocked new opportunities in the food industry. This study investigates the dynamic connection between the corpulence procedures and growth of the working feed. By analyzing existing research, administration rules, and manufacturing trends, we aim to clear up these two rules and recognize potential avenues for cooperation. Public Health Crisis: Obesity has enhanced an urgent global change in well-being, accompanied by important socioeconomic and health-accompanying results. Governments have generally acknowledged the need for effective procedures to address this issue. The advertising of working meals, encompassing foodstuffs defending accompanying health-advancing elements, has knowledgeable important growth. Consumers pursue products that offer energy benefits beyond their fundamental food. Governments are presenting and strengthening tactics to combat corpulence. These include marking requirements, carbohydrate taxes, and limits on ballyhoo sick foods, forging two challenges and providing space for working food manufacturing. The demand for working snacks is growing in response to increased knowledge. As a result, there is prime freedom for working cooking manufacturers to join their product contributions that accompany the corpulence policy aims. The display of working foodstuffs is evolving rapidly, accompanied by changes in fruit development, including the inclusion of bioactive compounds and digestive augmentations to support weight administration and overall well-being. Collaboration between public health experts and working cuisine manufacturing could promote the production of more healthy output and more effective procedure exercises
International Trade in Pharmaceutical Products Rehan Haider
International Journal of Applied Economics, Accounting and Management (IJAEAM) Vol. 1 No. 4 (2023): November 2023
Publisher : MultiTech Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59890/ijaeam.v1i4.913

Abstract

The global alternative to pharmaceutical products plays a pivotal role in ensuring global access to critical medicines, riding the economic boom, and fostering innovation in the healthcare sector. This summary delves into the multifaceted dimensions of international pharmaceutical trade by examining its significance, demanding situations, and destiny possibilities. Pharmaceutical alternatives encompass the import and export of various medicinal products together with prescribed drugs, vaccines, clinical devices, and energetic pharmaceutical ingredients. Globalization of pharmaceutical production has led to elaborate supply chains, where raw materials, research, manufacturing, and distribution span more than one international location. This interconnected ness has facilitated greater entry into drug treatments worldwide, especially in growing international locations, assisting in disease manipulation and public fitness. However, these challenges persist in the future. Regulatory disparities among international locations, including differing excellent requirements and intellectual asset protection, can obstruct change flows. Problems such as counterfeit capsules and the need for the harmonization of regulatory tactics complicate matters. Moreover, issues over affordability and equity get admissions to underscore the delicate stability among highbrow rights and public fitness priorities. The future of the global pharmaceutical trade is promising and uncertain. The ongoing COVID-19 pandemic has highlighted the importance of resilient delivery chains and collaborative research efforts. accelerated interest in telemedicine, and digital fitness solutions can reshape change dynamics. Furthermore, the controversy surrounding pharmaceutical patents and technology switches may affect trade rules and practices, particularly in the context of global health emergencies